N,N'-bis[2-(1,4-diazabicyclo[2.2.2]octan-2-yl)ethyl]-3-oxopentanediamide;N,N'-bis[2-[2-(dimethylamino)ethoxy]ethyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-3-oxopentanediamide;N,N'-bis[(1-ethylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;N,N'-bis[(1-methylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;3-oxo-N,N'-bis(2-piperidin-1-ylethyl)pentanediamide;3-oxo-N,N'-bis(2-pyrrolidin-1-ylethyl)pentanediamide;N,N,N',N'-tetrakis[2-(dimethylamino)ethyl]-3-oxopentanediamide

C165H310N40O29 — CID 160689528

IUPACN,N'-bis[2-(1,4-diazabicyclo[2.2.2]octan-2-yl)ethyl]-3-oxopentanediamide;N,N'-bis[2-[2-(dimethylamino)ethoxy]ethyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-3-oxopentanediamide;N,N'-bis[(1-ethylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;N,N'-bis[(1-methylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;3-oxo-N,N'-bis(2-piperidin-1-ylethyl)pentanediamide;3-oxo-N,N'-bis(2-pyrrolidin-1-ylethyl)pentanediamide;N,N,N',N'-tetrakis[2-(dimethylamino)ethyl]-3-oxopentanediamide
SMILESCCN1CCC(CNC(=O)CC(=O)CC(=O)NCC2CCN(CC)C2)C1.CN(C)CCCN(C)C(=O)CC(=O)CC(=O)N(C)CCCN(C)C.CN(C)CCCNC(=O)CC(=O)CC(=O)NCCCN(C)C.CN(C)CCN(CCN(C)C)C(=O)CC(=O)CC(=O)N(CCN(C)C)CCN(C)C.CN(C)CCOCCN(C)C(=O)CC(=O)CC(=O)N(C)CCOCCN(C)C.CN1CCC(CNC(=O)CC(=O)CC(=O)NCC2CCN(C)C2)C1.O=C(CC(=O)NCCC1CN2CCN1CC2)CC(=O)NCCC1CN2CCN1CC2.O=C(CC(=O)NCCN1CCCC1)CC(=O)NCCN1CCCC1.O=C(CC(=O)NCCN1CCCCC1)CC(=O)NCCN1CCCCC1
InChIInChI=1S/C21H36N6O3.C21H44N6O3.C19H38N4O5.2C19H34N4O3.2C17H30N4O3.C17H34N4O3.C15H30N4O3/c28-19(13-20(29)22-3-1-17-15-24-5-9-26(17)10-6-24)14-21(30)23-4-2-18-16-25-7-11-27(18)12-8-25;1-22(2)9-13-26(14-10-23(3)4)20(29)17-19(28)18-21(30)27(15-11-24(5)6)16-12-25(7)8;1-20(2)7-11-27-13-9-22(5)18(25)15-17(24)16-19(26)23(6)10-14-28-12-8-21(3)4;1-3-22-7-5-15(13-22)11-20-18(25)9-17(24)10-19(26)21-12-16-6-8-23(4-2)14-16;24-17(15-18(25)20-7-13-22-9-3-1-4-10-22)16-19(26)21-8-14-23-11-5-2-6-12-23;1-20-5-3-13(11-20)9-18-16(23)7-15(22)8-17(24)19-10-14-4-6-21(2)12-14;22-15(13-16(23)18-5-11-20-7-1-2-8-20)14-17(24)19-6-12-21-9-3-4-10-21;1-18(2)9-7-11-20(5)16(23)13-15(22)14-17(24)21(6)12-8-10-19(3)4;1-18(2)9-5-7-16-14(21)11-13(20)12-15(22)17-8-6-10-19(3)4/h17-18H,1-16H2,(H,22,29)(H,23,30);9-18H2,1-8H3;7-16H2,1-6H3;15-16H,3-14H2,1-2H3,(H,20,25)(H,21,26);1-16H2,(H,20,25)(H,21,26);13-14H,3-12H2,1-2H3,(H,18,23)(H,19,24);1-14H2,(H,18,23)(H,19,24);7-14H2,1-6H3;5-12H2,1-4H3,(H,16,21)(H,17,22)
InChIKeyRPFMKXRJWZYILD-UHFFFAOYSA-N
MW3318.55 g/mol
LogP-3.35
Rot. Bonds104

About N,N'-bis[2-(1,4-diazabicyclo[2.2.2]octan-2-yl)ethyl]-3-oxopentanediamide;N,N'-bis[2-[2-(dimethylamino)ethoxy]ethyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-3-oxopentanediamide;N,N'-bis[(1-ethylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;N,N'-bis[(1-methylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;3-oxo-N,N'-bis(2-piperidin-1-ylethyl)pentanediamide;3-oxo-N,N'-bis(2-pyrrolidin-1-ylethyl)pentanediamide;N,N,N',N'-tetrakis[2-(dimethylamino)ethyl]-3-oxopentanediamide

N,N'-bis[2-(1,4-diazabicyclo[2.2.2]octan-2-yl)ethyl]-3-oxopentanediamide;N,N'-bis[2-[2-(dimethylamino)ethoxy]ethyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-3-oxopentanediamide;N,N'-bis[(1-ethylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;N,N'-bis[(1-methylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;3-oxo-N,N'-bis(2-piperidin-1-ylethyl)pentanediamide;3-oxo-N,N'-bis(2-pyrrolidin-1-ylethyl)pentanediamide;N,N,N',N'-tetrakis[2-(dimethylamino)ethyl]-3-oxopentanediamide (PubChem CID 160689528) has the molecular formula C165H310N40O29 and a molecular weight of 3318.55 g/mol. Its IUPAC name is N,N'-bis[2-(1,4-diazabicyclo[2.2.2]octan-2-yl)ethyl]-3-oxopentanediamide;N,N'-bis[2-[2-(dimethylamino)ethoxy]ethyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-3-oxopentanediamide;N,N'-bis[(1-ethylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;N,N'-bis[(1-methylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;3-oxo-N,N'-bis(2-piperidin-1-ylethyl)pentanediamide;3-oxo-N,N'-bis(2-pyrrolidin-1-ylethyl)pentanediamide;N,N,N',N'-tetrakis[2-(dimethylamino)ethyl]-3-oxopentanediamide.

Molecular Properties

Compound NameN,N'-bis[2-(1,4-diazabicyclo[2.2.2]octan-2-yl)ethyl]-3-oxopentanediamide;N,N'-bis[2-[2-(dimethylamino)ethoxy]ethyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-3-oxopentanediamide;N,N'-bis[(1-ethylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;N,N'-bis[(1-methylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;3-oxo-N,N'-bis(2-piperidin-1-ylethyl)pentanediamide;3-oxo-N,N'-bis(2-pyrrolidin-1-ylethyl)pentanediamide;N,N,N',N'-tetrakis[2-(dimethylamino)ethyl]-3-oxopentanediamide
PubChem CID160689528
Molecular FormulaC165H310N40O29
Molecular Weight3318.55 g/mol
Exact Mass3316.40
IUPAC NameN,N'-bis[2-(1,4-diazabicyclo[2.2.2]octan-2-yl)ethyl]-3-oxopentanediamide;N,N'-bis[2-[2-(dimethylamino)ethoxy]ethyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-3-oxopentanediamide;N,N'-bis[(1-ethylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;N,N'-bis[(1-methylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;3-oxo-N,N'-bis(2-piperidin-1-ylethyl)pentanediamide;3-oxo-N,N'-bis(2-pyrrolidin-1-ylethyl)pentanediamide;N,N,N',N'-tetrakis[2-(dimethylamino)ethyl]-3-oxopentanediamide
SMILESCCN1CCC(CNC(=O)CC(=O)CC(=O)NCC2CCN(CC)C2)C1.CN(C)CCCN(C)C(=O)CC(=O)CC(=O)N(C)CCCN(C)C.CN(C)CCCNC(=O)CC(=O)CC(=O)NCCCN(C)C.CN(C)CCN(CCN(C)C)C(=O)CC(=O)CC(=O)N(CCN(C)C)CCN(C)C.CN(C)CCOCCN(C)C(=O)CC(=O)CC(=O)N(C)CCOCCN(C)C.CN1CCC(CNC(=O)CC(=O)CC(=O)NCC2CCN(C)C2)C1.O=C(CC(=O)NCCC1CN2CCN1CC2)CC(=O)NCCC1CN2CCN1CC2.O=C(CC(=O)NCCN1CCCC1)CC(=O)NCCN1CCCC1.O=C(CC(=O)NCCN1CCCCC1)CC(=O)NCCN1CCCCC1
InChIInChI=1S/C21H36N6O3.C21H44N6O3.C19H38N4O5.2C19H34N4O3.2C17H30N4O3.C17H34N4O3.C15H30N4O3/c28-19(13-20(29)22-3-1-17-15-24-5-9-26(17)10-6-24)14-21(30)23-4-2-18-16-25-7-11-27(18)12-8-25;1-22(2)9-13-26(14-10-23(3)4)20(29)17-19(28)18-21(30)27(15-11-24(5)6)16-12-25(7)8;1-20(2)7-11-27-13-9-22(5)18(25)15-17(24)16-19(26)23(6)10-14-28-12-8-21(3)4;1-3-22-7-5-15(13-22)11-20-18(25)9-17(24)10-19(26)21-12-16-6-8-23(4-2)14-16;24-17(15-18(25)20-7-13-22-9-3-1-4-10-22)16-19(26)21-8-14-23-11-5-2-6-12-23;1-20-5-3-13(11-20)9-18-16(23)7-15(22)8-17(24)19-10-14-4-6-21(2)12-14;22-15(13-16(23)18-5-11-20-7-1-2-8-20)14-17(24)19-6-12-21-9-3-4-10-21;1-18(2)9-7-11-20(5)16(23)13-15(22)14-17(24)21(6)12-8-10-19(3)4;1-18(2)9-5-7-16-14(21)11-13(20)12-15(22)17-8-6-10-19(3)4/h17-18H,1-16H2,(H,22,29)(H,23,30);9-18H2,1-8H3;7-16H2,1-6H3;15-16H,3-14H2,1-2H3,(H,20,25)(H,21,26);1-16H2,(H,20,25)(H,21,26);13-14H,3-12H2,1-2H3,(H,18,23)(H,19,24);1-14H2,(H,18,23)(H,19,24);7-14H2,1-6H3;5-12H2,1-4H3,(H,16,21)(H,17,22)
InChIKeyRPFMKXRJWZYILD-UHFFFAOYSA-N
XLogP-3.35
TPSA714.43 Ų
H-Bond Donors12
H-Bond Acceptors51
Rotatable Bonds104
Heavy Atoms234
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003318.55
LogP ≤ 5-3.35
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1051

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}

Analyze N,N'-bis[2-(1,4-diazabicyclo[2.2.2]octan-2-yl)ethyl]-3-oxopentanediamide;N,N'-bis[2-[2-(dimethylamino)ethoxy]ethyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-3-oxopentanediamide;N,N'-bis[(1-ethylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;N,N'-bis[(1-methylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;3-oxo-N,N'-bis(2-piperidin-1-ylethyl)pentanediamide;3-oxo-N,N'-bis(2-pyrrolidin-1-ylethyl)pentanediamide;N,N,N',N'-tetrakis[2-(dimethylamino)ethyl]-3-oxopentanediamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N,N'-bis[2-(1,4-diazabicyclo[2.2.2]octan-2-yl)ethyl]-3-oxopentanediamide;N,N'-bis[2-[2-(dimethylamino)ethoxy]ethyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-3-oxopentanediamide;N,N'-bis[(1-ethylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;N,N'-bis[(1-methylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;3-oxo-N,N'-bis(2-piperidin-1-ylethyl)pentanediamide;3-oxo-N,N'-bis(2-pyrrolidin-1-ylethyl)pentanediamide;N,N,N',N'-tetrakis[2-(dimethylamino)ethyl]-3-oxopentanediamide?
The IUPAC name of N,N'-bis[2-(1,4-diazabicyclo[2.2.2]octan-2-yl)ethyl]-3-oxopentanediamide;N,N'-bis[2-[2-(dimethylamino)ethoxy]ethyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-3-oxopentanediamide;N,N'-bis[(1-ethylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;N,N'-bis[(1-methylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;3-oxo-N,N'-bis(2-piperidin-1-ylethyl)pentanediamide;3-oxo-N,N'-bis(2-pyrrolidin-1-ylethyl)pentanediamide;N,N,N',N'-tetrakis[2-(dimethylamino)ethyl]-3-oxopentanediamide (CID 160689528) is N,N'-bis[2-(1,4-diazabicyclo[2.2.2]octan-2-yl)ethyl]-3-oxopentanediamide;N,N'-bis[2-[2-(dimethylamino)ethoxy]ethyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-3-oxopentanediamide;N,N'-bis[(1-ethylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;N,N'-bis[(1-methylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;3-oxo-N,N'-bis(2-piperidin-1-ylethyl)pentanediamide;3-oxo-N,N'-bis(2-pyrrolidin-1-ylethyl)pentanediamide;N,N,N',N'-tetrakis[2-(dimethylamino)ethyl]-3-oxopentanediamide.
What is the SMILES notation for N,N'-bis[2-(1,4-diazabicyclo[2.2.2]octan-2-yl)ethyl]-3-oxopentanediamide;N,N'-bis[2-[2-(dimethylamino)ethoxy]ethyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-3-oxopentanediamide;N,N'-bis[(1-ethylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;N,N'-bis[(1-methylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;3-oxo-N,N'-bis(2-piperidin-1-ylethyl)pentanediamide;3-oxo-N,N'-bis(2-pyrrolidin-1-ylethyl)pentanediamide;N,N,N',N'-tetrakis[2-(dimethylamino)ethyl]-3-oxopentanediamide?
The canonical SMILES for N,N'-bis[2-(1,4-diazabicyclo[2.2.2]octan-2-yl)ethyl]-3-oxopentanediamide;N,N'-bis[2-[2-(dimethylamino)ethoxy]ethyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-3-oxopentanediamide;N,N'-bis[(1-ethylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;N,N'-bis[(1-methylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;3-oxo-N,N'-bis(2-piperidin-1-ylethyl)pentanediamide;3-oxo-N,N'-bis(2-pyrrolidin-1-ylethyl)pentanediamide;N,N,N',N'-tetrakis[2-(dimethylamino)ethyl]-3-oxopentanediamide is CCN1CCC(CNC(=O)CC(=O)CC(=O)NCC2CCN(CC)C2)C1.CN(C)CCCN(C)C(=O)CC(=O)CC(=O)N(C)CCCN(C)C.CN(C)CCCNC(=O)CC(=O)CC(=O)NCCCN(C)C.CN(C)CCN(CCN(C)C)C(=O)CC(=O)CC(=O)N(CCN(C)C)CCN(C)C.CN(C)CCOCCN(C)C(=O)CC(=O)CC(=O)N(C)CCOCCN(C)C.CN1CCC(CNC(=O)CC(=O)CC(=O)NCC2CCN(C)C2)C1.O=C(CC(=O)NCCC1CN2CCN1CC2)CC(=O)NCCC1CN2CCN1CC2.O=C(CC(=O)NCCN1CCCC1)CC(=O)NCCN1CCCC1.O=C(CC(=O)NCCN1CCCCC1)CC(=O)NCCN1CCCCC1.
What is the InChIKey of N,N'-bis[2-(1,4-diazabicyclo[2.2.2]octan-2-yl)ethyl]-3-oxopentanediamide;N,N'-bis[2-[2-(dimethylamino)ethoxy]ethyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-3-oxopentanediamide;N,N'-bis[(1-ethylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;N,N'-bis[(1-methylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;3-oxo-N,N'-bis(2-piperidin-1-ylethyl)pentanediamide;3-oxo-N,N'-bis(2-pyrrolidin-1-ylethyl)pentanediamide;N,N,N',N'-tetrakis[2-(dimethylamino)ethyl]-3-oxopentanediamide?
The InChIKey is RPFMKXRJWZYILD-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H36N6O3.C21H44N6O3.C19H38N4O5.2C19H34N4O3.2C17H30N4O3.C17H34N4O3.C15H30N4O3/c28-19(13-20(29)22-3-1-17-15-24-5-9-26(17)10-6-24)14-21(30)23-4-2-18-16-25-7-11-27(18)12-8-25;1-22(2)9-13-26(14-10-23(3)4)20(29)17-19(28)18-21(30)27(15-11-24(5)6)16-12-25(7)8;1-20(2)7-11-27-13-9-22(5)18(25)15-17(24)16-19(26)23(6)10-14-28-12-8-21(3)4;1-3-22-7-5-15(13-22)11-20-18(25)9-17(24)10-19(26)21-12-16-6-8-23(4-2)14-16;24-17(15-18(25)20-7-13-22-9-3-1-4-10-22)16-19(26)21-8-14-23-11-5-2-6-12-23;1-20-5-3-13(11-20)9-18-16(23)7-15(22)8-17(24)19-10-14-4-6-21(2)12-14;22-15(13-16(23)18-5-11-20-7-1-2-8-20)14-17(24)19-6-12-21-9-3-4-10-21;1-18(2)9-7-11-20(5)16(23)13-15(22)14-17(24)21(6)12-8-10-19(3)4;1-18(2)9-5-7-16-14(21)11-13(20)12-15(22)17-8-6-10-19(3)4/h17-18H,1-16H2,(H,22,29)(H,23,30);9-18H2,1-8H3;7-16H2,1-6H3;15-16H,3-14H2,1-2H3,(H,20,25)(H,21,26);1-16H2,(H,20,25)(H,21,26);13-14H,3-12H2,1-2H3,(H,18,23)(H,19,24);1-14H2,(H,18,23)(H,19,24);7-14H2,1-6H3;5-12H2,1-4H3,(H,16,21)(H,17,22).
What are the key properties of N,N'-bis[2-(1,4-diazabicyclo[2.2.2]octan-2-yl)ethyl]-3-oxopentanediamide;N,N'-bis[2-[2-(dimethylamino)ethoxy]ethyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-3-oxopentanediamide;N,N'-bis[(1-ethylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;N,N'-bis[(1-methylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;3-oxo-N,N'-bis(2-piperidin-1-ylethyl)pentanediamide;3-oxo-N,N'-bis(2-pyrrolidin-1-ylethyl)pentanediamide;N,N,N',N'-tetrakis[2-(dimethylamino)ethyl]-3-oxopentanediamide?
N,N'-bis[2-(1,4-diazabicyclo[2.2.2]octan-2-yl)ethyl]-3-oxopentanediamide;N,N'-bis[2-[2-(dimethylamino)ethoxy]ethyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-3-oxopentanediamide;N,N'-bis[(1-ethylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;N,N'-bis[(1-methylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;3-oxo-N,N'-bis(2-piperidin-1-ylethyl)pentanediamide;3-oxo-N,N'-bis(2-pyrrolidin-1-ylethyl)pentanediamide;N,N,N',N'-tetrakis[2-(dimethylamino)ethyl]-3-oxopentanediamide has a molecular weight of 3318.55 g/mol, XLogP of -3.35, 104 rotatable bonds, 12 hydrogen bond donors, and 51 hydrogen bond acceptors.
Where does this data come from?
All data for N,N'-bis[2-(1,4-diazabicyclo[2.2.2]octan-2-yl)ethyl]-3-oxopentanediamide;N,N'-bis[2-[2-(dimethylamino)ethoxy]ethyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-N,N'-dimethyl-3-oxopentanediamide;N,N'-bis[3-(dimethylamino)propyl]-3-oxopentanediamide;N,N'-bis[(1-ethylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;N,N'-bis[(1-methylpyrrolidin-3-yl)methyl]-3-oxopentanediamide;3-oxo-N,N'-bis(2-piperidin-1-ylethyl)pentanediamide;3-oxo-N,N'-bis(2-pyrrolidin-1-ylethyl)pentanediamide;N,N,N',N'-tetrakis[2-(dimethylamino)ethyl]-3-oxopentanediamide is sourced from PubChem (CID 160689528), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).